



EFFECTIVENESS OF AN EDUCATIONAL PROGRAM TO REDUCE SEPSIS
MORTALITY IN SEVERAL HOSPITALS IN SPAIN
C. Salazar Ramirez1, I. Bellido Este´vez2, M. V. de la Torre-Prados1
1H. U. Virgen de la Victoria, Intensive Care Unit, Malaga, Spain, 2Medical School Malaga,
Pharmacology and Clinical Therapeutic, Malaga, Spain
INTRODUCTION. To determine the effectiveness of an educational program based on
Surviving Sepsis Campaign guidelines to reduce sepsis mortality in several hospitals in Spain.
METHODS. Eleven Spanish ICUs, in the South of Spain (Andalucia) were included in a
prospective study. A multicentric study realised during 2005 and 2006. We determined the
rate of compliance of the resuscitation bundle (first 6 h) and the management bundle (first
24 h) during 2 months before the educational program and 4 months after the educational
program.
RESULTS. Three hundred and thirty patients were enrolled in this analysis: severe sepsis
(29.4%) or septic shock (70.6%) admitted in intensive care units. There were no significant
differences between the groups with respect to base-line characteristics and severity of illness
measured by the Acute Physiology and Chronic Health Evaluation II were similar for both
groups. Patients characteristics were as follows: age, 62 (60, 63) years; APACHE II score, 21
(20, 22). The main sources of infection were: lung (36.1%), abdomen (28.1%) and UTI (11%).
CVP and Svc02 monitoring, antibiotics, fluid resuscitation, mechanical ventilation, vaso-
pressors, inotropes, corticosteroides, and rhAPC were included in the educational program.
The patients in the after EP period had measured more Svc02 (36.2 vs. 15.5%), CVP (45.7 vs.
39.9%) and lactate (27.7 vs. 23.2%) All patients received broad-spectrum antibiotics, patient
in the after group received more corticosteroids (35 vs. 25%), a lower lactate (3.8 vs.
5.19 mmol/l), blood culture (47.4 vs. 37.5%), were more likely to receive intravenous fluids of
[20 ml/kg body weight before vasopressor administration (38 vs. 36%), patient in the after
group were less likely to require vasopressor (43 vs. 47%). In the after EP period these
patients had a shorter length of stay in intensive care (238 vs. 280 h, we reduced the length in
15.1%) and shorter hospital length of stay (688 vs. 719 h). Mortality in ICU pre-EP was
43.8% and after-EP was 31.6%. The percentage of compliance with 6-h and 24-h bundle in
the after-EP increased, respectively (9.85%, P \ 0.01 and 8.86%), total compliance was also
46.62%.
CONCLUSIONS. Our study found the implementation of a standardized order set for the
management of septic shock was associated with an important decreased of the mortality
(12.2%), improving early and accurate diagnosis and increasing the use of appropriate
treatment and interventions.
REFERENCE(S). 1. Ferrer R, Artigas A, Levy MM, Blanco J, Gonza´lez-Dı´az G, Garnacho-
Montero J, Iba´n˜ez J, Palencia E, Quintana M, de la Torre-Prados MV; Edusepsis Study Group
(2008) Improvement in process of care and outcome after a multicenter severe sepsis edu-
cational program in Spain. JAMA 299(19):2294–2303. 2. Dellinger RP et al (2004) Surviving
Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med
32(3):858–873
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CONVERTING GUIDELINE TO PRACTICE: EXPERIENCE IN IMPLEMENTING
SEPSIS RESUSCITATION BUNDLE FOR SEVERE SEPSIS AND SEPTIC SHOCK
IN THE EMERGENCY DEPARTMENT
Z. Wang1
1Peking University 3rd Hospital, Beijing, China
INTRODUCTION. Patients with severe sepsis and septic shock have a mortality rate of 30–
50%. It is well recognized that sepsis outcomes are directly related to delays in diagnosis and
treatment. The aim of this study was to compare the mortality of two group patients before
and after implementing sepsis resuscitation bundle in the emergency department.
METHODS. This is a prospective study. The studied population included severe sepsis and
septic shock patients entered in the Surviving Sepsis Campaign (SSC) data base, who were
admitted to the emergency department of an urban tertiary care medical center during Sep
2008–April 2009. They were divided into two groups based on the admission time (Group 1:
Sep 2008–Dec 2008, baseline survey of real practice in sepsis therapy before creating a
protocol. Group 2: Jan 2009–April 2009, creating a protocol implementing sepsis resuscita-
tion bundle in sepsis therapy). Acute physiology and chronic health evaluation (APACHE II)
scores and in-hospital mortality were compared.
RESULTS. One hundred and twenty-five (125) severe sepsis and septic shock patients were
included, mortality was 60.5% in group 1 and 51% in group 2 (P \ 0.05). No significant
differences were noted among two groups with respect to age, gender, lactic acid level,
median APACHE II score. Sepsis resuscitation bundle compliance was 1% in group 1 and 9%
in group 2 (P \ 0.05).
CONCLUSIONS. The results revealed a mortality benefit after implementing sepsis resus-
citation bundle in the emergency department. Sepsis guideline could reliably be implemented
better in real-world clinical practice if creating a protocol.
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EFFECTIVENESS OF TREATMENTS FOR SEVERE SEPSIS: A PROSPECTIVE
MULTICENTER OBSERVATIONAL STUDY IN SPANISH ICUS
R. Ferrer Roca1, Edusepsis Study Group
1Sabadell Hospital, CSPT. UAB. CIBER-ER, Sabadell, Spain
INTRODUCTION. The improvement of the compliance of the Surviving Sepsis Campaign
(SSC) guidelines was able to reduce mortality (Edusepsis study, Ferrer et al. JAMA 2008).
OBJECTIVE. To analyze the impact on hospital mortality of severe sepsis treatments
included in the SSC guidelines in a prospective multicenter observational study.
METHODS. We included all consecutive adult patients with severe sepsis or septic shock
from the 77 participating intensive care units (ICU) from the database of the Edusepsis study.
Treatments evaluated were those included in the SSC bundles: Early administration of broad
spectrum antibiotics (time from severe sepsis presentation to antibiotic administration: first
hour, 1–3 h, 3–6 h, previous antibiotic or no antibiotic administered in the first 6 h), fluid
challenge of a minimum of 20 ml/kg of crystalloid (or colloid equivalent) in the event of
hypotension and/or lactate [36 mg/dl, low-dose steroids in the event of persistent hypoten-
sion despite fluid resuscitation and/or lactate[36 mg/dL, and drotrecogin alfa (activated) for
multiorgan failure. The primary outcome measure was hospital mortality. The effectiveness of
each of the four treatments was estimated by using Propensity Scores (PS) in the sub-sample
where the treatment was indicated. All risks factors for mortality, therapeutic goals of the SSC
bundles (CVP C8 mm Hg, ScvO2 C70%, blood glucose \150 mg/dl without hypoglycemia
and inspiratory plateau pressure \30 cmH2O) and the other treatments were included in the
PS models. In order to assess the balancing of covariates between treated and untreated groups
in each PS quintile we adopted a fully exhaustive approach comparing all the covariates for
treated and untreated groups within each quintile, along with a graphical approach plotting
box plots of the estimated PSs for treated and untreated patients within each quintile. For each
assessed treatment, to take into account potential residual imbalances in the final model, we
included all the covariates that showed a statistically significant difference between treated
and untreated groups in some quintile and APACHE II.
RESULTS. Of 2,796 patients, 1,164 (41.6%) died before hospital discharge. The mean age of
all subjects was 62.2 years, mean APACHE II was 21, mainly were male (61.4%) and
predominantly with medical septic conditions (62.2%); pneumonia (26.5%) was the most
common infection. Two therapeutic interventions were associated with lower hospital mor-
tality: administration of broad spectrum antibiotic treatment in the first hour of severe sepsis
(OR 0.65; 95% CI 0.49–0.88; P = 0.005) and administration of drotrecogin alfa (activated) in
multiorgan failure (OR 0.59; 95% CI 0.42–0.85; P = 0.004).
CONCLUSION. Early administration of antibiotics in all patients and drotrecogin alfa
(activated) in the most severe patients are able to reduce severe sepsis mortality.
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EFFECT OF SEPSIS STAGING-DIRECTED THERAPY (SSDT) IN THE TREAT-
MENT OF SEVERE SEPSIS AND SEPTIC SHOCK
S.-H. Wang1, C. W. Lam1, T.-S. Wei2, S.-J. Kou3, H.-C. Chang3, S. H. Lin1
1Changhua Christian Hospital, Critical Care Division of Surgical Department, Changhua,
Taiwan, Republic of China, 2Changhua Christian Hospital, Department of Medical Education
and Research, Changhua, Taiwan, Republic of China, 3Changhua Christian Hospital, Surgical
Department, Changhua, Taiwan, Republic of China
BACKGROUND. Surviving Sepsis Campaign (SSC) management guidelines are crucial to
the survival of severe sepsis and septic shock. Sepsis-related Organ Failure Assessment
(SOFA) score is an important tool for severity of sepsis related organ failure. Based on the
SSC guideline and SOFA score, we develop a Sepsis Staging-Directed Therapy (SSDT)
system to guide sepsis bundle treatment on severe sepsis and septic shock.
METHODS. In a single center, surgical intensive care unit, prospective cohort study, we
classified sepsis into five stages which stage I was uncomplicated, stage II and stage III were
severe sepsis, and stage IV and stage V were septic shock. We surveyed severe sepsis and
septic shock patients before and after SSDT implementation. The primary end point was the
mortality rate 28 days after presentation of severe sepsis or septic shock.
RESULTS. A total of 557 patients (298 patients were historical control group, and 259
patients were SSDT intervention group) were enrolled and included in analysis. There were
significant difference between SSDT intervention group and historical control group in 28-day
mortality rate (18.9 and 30.9%, respectively; P = 0.001), in-hospital mortality rate (27.0 and
44.3%, respectively; P \ 0.001). The multivariate logistic regression analysis showed that
SOFA score and SSDT were independent prognostic predictors of 28-day mortality
(OR = 0.79; 95% CI = 0.67–0.93; P = 0.005 and OR = 0.42; 95% CI = 0.23–0.75;
P = 0.004, respectively) and in-hospital mortality (OR = 0.80; 95% CI = 0.69–0.94;
P = 0.006 and OR = 0.32; 95% CI = 0.18–0.57; P \ 0.001, respectively).
CONCLUSIONS. Stratified sepsis to a sepsis stage system according to SOFA score is an
innovative try and useful for clinical therapy intervention. The SSDT effectively improved the
outcome of severe sepsis and septic shock. We supposed that SSDT system could be widely
implemented in a multicenter, multi-country for further research.
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THE EFFECT OF TRANSCUTANEOUS ELECTRIC MUSCLE STIMULATION ON
LOSS OF MUSCLE MASS IN ICU PATIENTS WITH SEPTIC SHOCK
J. B. Poulsen1, K. Møller1, H. Kehlet2, A. Perner1
1Rigshospitalet, University of Copenhagen, Department of Intensive Care, Copenhagen,
Denmark, 2Rigshospitalet, University of Copenhagen, Section for Surgical Pathophysiology,
Copenhagen, Denmark
BACKGROUND. ICU admission for septic shock is associated with loss of muscle mass and
functional limitations [1]. We investigated the effect of early transcutaneous electric muscle
stimulation (TEMS) on muscle mass of the quadriceps muscle in septic patients.
METHODS. We included seven adult patients with septic shock within 72 h of diagnosis.
Exclusion criteria were diabetes, infection in or trauma to the lower extremities, corticosteroid
treatment equivalent to prednisolone dose[1 mg/kg/day, predicted ICU stay of\7 days and
clinical conditions that constituted a contraindication for computed tomography (CT).
Patients were randomised to unilateral TEMS of the quadriceps muscle. The contra-lateral leg
served as control. Stimulation was done daily for 60 min in seven consecutive days via carbon
5 9 5 cm and 5 9 9 cm pad electrodes and using a battery-powered stimulator (Danmeter,
Elalpha 3000) programmed to evoke contractions at 33 Hz at intervals of 3 s separated by 6-s
intervals. The distal electrode was placed over the motor point, which was identified as the
point with the lowest threshold to produce a visible twitch in response to an electrical pulse.
Each day the threshold value was determined as the current resulting in barely visible muscle
contraction. The stimulating current was set at 50% above the threshold current, corre-
sponding to moderate training intensity. All patients underwent CT scanning of both thighs
before and after 7 days of TEMS. The quadriceps muscles were manually delineated on the
CT slides, and muscle volumes were automatically calculated after 3-D reconstruction. The
patients were otherwise treated according to standard protocols for resuscitation, antibiotics,
source control, sedation and nutrition. All patients were ventilated and confined to bed-rest
throughout the study period as a consequence of their critical illness.
RESULTS. Mean age and SAPS II of the patients were 69 years (SD 6) and 55 (SD 9),
respectively. During the 7-day study period, muscle volume in the stimulated muscle
decreased by mean 17% (SD 15, P = 0.02, compare to baseline by paired t test) corre-
sponding to a rate of 2.4%/day. Control muscle volume decreased by 14% (SD 13, P = 0.03),
i.e. 2.0%/day. There was no difference in the mean changes in muscle volume between the
stimulated and control leg (P = 0.17 by paired t test).
CONCLUSION. We observed a marked decrease in quadriceps volume in the first week of
intensive care for septic shock. However, this loss of muscle mass was unaffected by TEMS
applied for 60 min/day.
REFERENCE(S). 1. Poulsen JB, Møller K, Kehlet H, Perner A. Long-term physical outcome
in patients with septic shock. Acta Anaesthesiol Scand (in press)
Acute lung injury: Innovative therapies: 0006–0010
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SYSTEMATIC TWO-DAY MUSCLE RELAXANTS COURSE IN THE EARLY
PHASE OF SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME. A MULTI-
CENTER RANDOMIZED CONTROLLED TRIAL
L. Papazian1, J.-M. Forel2, A. Gacouin3, G. Perrin2, S. Jaber4, J.-M. Arnal5, D. Perez6,
J.-M. Seghboyan7, J.-M. Constantin8, P. Courant9, A. Roch2, ACURASYS study group
1Hoˆpital Sainte-Marguerite, Re´animation Me´dicale, Marseille, France, 2Hoˆpital Sainte-Mar-
guerite, Marseille, France, 3Hoˆpital Pontchaillou, Rennes, France, 4Hoˆpital Gui de Chauliac,
Montpellier, France, 5Hoˆpital Font-Pre´, Toulon, France, 6Hoˆpital Jean Minjoz, Besanc¸on,
France, 7Hoˆpital Ambroise Pare´, Marseille, France, 8Hoˆpital Hoˆtel Dieu, Clermont-Ferrand,
France, 9Centre Hospitalier, Avignon, France
INTRODUCTION. The use of neuromuscular blocking agents (NMBA) remains contro-
versial, empirical and no clear recommendation is available. In the context of a proven
reduction of mortality of ARDS when a lung-protective MV (limitation of tidal volume and
plateau pressure) is applied, muscular paralysis induced by NMBA in a lung-protective
ventilation should be considered.
OBJECTIVES. We conducted a multicenter randomized, controlled trial to determine the
efficacy and safety of NMBA.
METHODS. Patients receiving endotracheal mechanical ventilation for hypoxemic acute
respiratory failure were eligible if the following criteria were met for no more than 48 h
before enrollment: PaO2:FIO2 \150 mm Hg at time of enrollment while a PEEP of at least
5 cmH2O and a tidal volume of 6–8 ml/kg were applied, recent appearance of bilateral
pulmonary infiltrates consistent with edema, and no clinical evidence of left atrial hyper-
tension (pulmonary-capillary wedge pressure\18 mm Hg, when available). After obtaining a
Ramsay sedation score of VI and optimizing the ventilator settings according to the ventilator
procedure, cisatracurium or placebo were administered during 48 h.
RESULTS. We screened 1,326 patients at 20 French centers during the study period. 177
patients were included in hte NMBA group, and 162 to the control group. The two groups
were similar with respect to demographic characteristics, reason for ICU admission, cause of
lung injury, and measures of the severity of illness at baseline. However, in the NMBA group,
the mean PaO2:FiO2 was significantly lower (P = 0.03). The 90-day mortality rate was 31.6
percent (95% CI, 25.2–38.8%) in the group treated with NMBA and 40.7% (95% CI, 33.5–
48.4%) in the placebo group (P = 0.08), for an absolute difference of -9.1% (95% confi-
dence interval for the difference between groups, -19.3 to 1.1%). The Cox regression model
(group assignment, SAPS 2, plateau pressure and PaO2:FiO2 ratio) yielded an adjusted hazard
ratio for death at 90 days for the NMBA group compared with the control group of 0.68 (95%
CI, 0.48–0.98) (P = 0.04).The 28-day mortality rate was 23.7% in the group treated with
NMBA and 33.3% in the group who received placebo (RR, 0.71 [95% CI, 0.51–1.00],
P = 0.05). The NMBA group had significantly more ventilator-free than the placebo group
during the first 28 days as well as at 90 days. As compared with the placebo group, the
NMBA group had significantly more failure-free days for other organs than lung during the
first 28 days (3.6 days, P = 0.002). There were no difference concerning the incidence of
muscular weakness evaluated by the MRC score either at day 28 or at ICU discharge. There
were more patients from the control group (11.7%) than from the NMBA group (5.1%) who
developed an episode of pneumothorax (P = 0.03).
CONCLUSIONS. A systematic short course of NMBA improved outcome in severe ARDS.
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HIGH FREQUENCY OSCILLATION AND TRACHEAL GAS INSUFFLATION FOR
SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME: RESULTS FROM A
SINGLE-CENTER, PHASE II, RANDOMIZED CONTROLLED TRIAL
[NCT00416260]
S. Malachias1, S. Kokkoris1, S. Zakynthinos1, S. D. Mentzelopoulos1
1University of Athens, Intensive Care Medicine, Athens, Greece
INTRODUCTION. Animal data supports the use of high-frequency oscillation (HFO) in
acute respiratory distress syndrome (ARDS). Preceding clinical comparisons of HFO and
conventional mechanical ventilation (CMV) were inconclusive. Combined HFO and tracheal-
gas insufflation (TGI) improves oxygenation versus standard HFO and lung-protective CMV
[1], thus potentially enabling reduction of ventilation pressures. We hypothesized that
intermittent HFO-TGI may improve respiratory function and impact survival in patients with
early and severe ARDS, ventilated with pressure- and volume-limited, lung-protective CMV
(plateau-pressure target B30 cmH2O, tidal volume = 5.5–7.5 mL/kg predicted body weight).
METHODS. We performed a prospective, randomized, unblinded, parallel-group, controlled
trial in a 37-bed university intensive care unit. We studied a total of 54 patients with early
(B72 h in duration) ARDS and severe oxygenation disturbances (PaO2/FiO2 of\150 mm Hg
for [12 consecutive hours with positive end-expiratory pressure C8 cmH2O). Patients were
randomly assigned to the intervention (HFO-TGI) group (n = 27) or the control (CMV)
group (n = 27). HFO-TGI group received sessions of HFO-TGI (whenever PaO2/FiO2
\150 mmHg for [12 consecutive hours), followed by lung-protective CMV. CMV group
received lung-protective CMV.
RESULTS. Within days 1–8 post-randomization, HFO-TGI group received 116 sessions of
HFO-TGI (duration-range: 6–48 h). During days 1–8, oxygenation, plateau-pressure and
respiratory compliance were improved in HFO-TGI group versus CMV group (P B 0.001).
Within days 1–60, HFO-TGI versus CMV group had more ventilator-free days, and more
days without respiratory, coagulation, liver, renal, and any organ failure (P = 0.047–0.003);
barotrauma incidence and length of hospital stay were similar. HFO-TGI group versus CMV
group had improved survival to days 28 and 60 (P = 0.02–0.03), but not to hospital discharge
(16/27, 59.3% vs. 9/27, 33.3%; P = 0.10).
CONCLUSION. In severe ARDS, intermittent HFO-TGI (interspersed with CMV) improves
respiratory function and short-term clinical course, but not in-hospital mortality, length of
hospital stay, or barotrauma.
GRANT ACKNOWLEDGEMENT. Supported in part by the Thorax Foundation.
REFERENCE(S). 1. Mentzelopoulos SD et al (2007) Crit Care Med 35:1500–1508
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PULMONARY VASCULAR LEAKAGE AFTER COMBINED BURN AND SMOKE
INHALATION INJURY IS REDUCED BY CONTINUOUS INTRAVENOUS INFU-
SION OF RECOMBINANT HUMAN ANTITHROMBIN DUE TO INHIBITION OF
NEUTROPHIL ACTIVATION
S. Rehberg1, Y. Yamamoto1, D. L. Traber1, Y. Zhu1, C. Jonkam1, L. Sousse1, K. Bansal1, M.
O. Maybauer1, D. M. Maybauer1, L. D. Traber1, P. Enkhbaatar1
1The University of Texas Medical Branch, Anesthesiology, Galveston, United States
INTRODUCTION. Antithrombin (AT) was shown to inhibit endotoxin-induced endothelial
adherence of neutrophils by binding at the Syndecan-4 receptor [1].
OBJECTIVES. We hypothesized that AT reduces the transition of neutrophils into the lymph
and thereby pulmonary vascular permeability. Therefore, this randomized, controlled study
was designed to investigate the effects of a continuous, intravenous infusion of recombinant
human antithrombin (rhAT) on pulmonary lymph neutrophil count and flow as well as pul-
monary function in an established ovine model of combined burn and smoke inhalation
injury.
METHODS. Female sheep (n = 9) were instrumented for chronic hemodynamic monitoring.
After 5 days of recovery, a tracheostomy as well as a 40% total body surface area 3rd degree
cutaneous burn and smoke inhalation injury (48 breaths of cold cotton smoke \40C) were
performed under deep anesthesia. Sheep were then randomly assigned to receive either an i.v.
infusion of 6 U kg-1 h-1 rhAT (n = 4) or only the vehicle (normal saline; n = 5). All sheep
were mechanically ventilated and fluid resuscitated during the 48 h-study period. The rhAT
treatment was started 1 h after injury. Permeability index was calculated according to the
formula: lymph flow*lymph protein/plasma protein. Data are expressed as mean ± SE.
RESULTS. Baseline (BL) values and carboxy hemoglobin after smoke inhalation did not
differ between groups. While AT plasma levels decreased to 66% of BL in the control group,
rhAT treatment kept AT plasma levels 5–10% above BL value. Compared to control animals,
rhAT decreased mean pulmonary artery pressures from 12 h on (26 ± 1 vs. 30 ± 1 mmHg),
reduced pulmonary shunt fraction (28 ± 8 vs. 47 ± 3% at 48 h) and attenuated the decrease
in PaO2/FiO2 ratio (288 ± 72 vs. 135 ± 16 mmHg at 24 h; P \ 0.05 each). Starting at 9 h,
lung lymph flow (4 ± 1 vs. 27 ± 5 mL/h), pulmonary protein flux (13 ± 3 vs. 69 ± 7 mg/h)
and permeability index (4 ± 2 vs. 21 ± 2 mL/h) were significantly lower than in the control
group (P \ 0.01 each). The neutrophil count was markedly reduced in rhAT treated animals
compared to control after 24 h (42 ± 23% of BL vs. 192 ± 52% of BL; P = 0.047) and 48 h
(50 ± 22% of BL vs. 330 ± 64% of BL; P = 0.014). In addition, cumulative positive net
fluid balance was lower in the rhAT (780 ± 750 mL) than in the control group
(4457 ± 408 mL; P = 0.003).
CONCLUSIONS. Continuous intravenous infusion of rhAT reduces pulmonary vascular
permeability and improves pulmonary function after combined burn and smoke inhalation
injury. The inhibition of neutrophil transition into the lung lymph might represent a potential
mechanism of action. Notably, systemic vascular leakage as represented by the cumulative
fluid balance was also reduced in rhAT treated animals.
REFERENCE(S). 1. Kaneider NC et al (2003) Thromb Haemost 90:1150–1157
GRANT ACKNOWLEDGEMENT. This study was supported by The Shriners of North
America (#8630).
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NON INVASIVE VENTILATION (NIV) BY HELMET FOR TREATMENT OF
HYPOXEMIC ACUTE RESPIRATORY FAILURE (ARF): PRESSURE SUPPORT
(PS) VS. NEURALLY ADJUSTED VENTILATORY ASSIST (NAVA)
G. Cammarota 1, R. Costa2, C. Blando1, F. Longhini1, D. Colombo1, R. Vaschetto1,
G. Spinazzola2, F. Della Corte1, G. Conti2, P. Navalesi1
1University of Eastern Piedmont, SCDU Anestesia e Rianimazione, Novara, Italy, 2Universita`
Cattolica del Sacro Cuore, Anestesia e Rianimazione, Rome, Italy
INTRODUCTION. NIV can be applied in PS mode by means of a helmet. The helmet is less
efficient than the face-mask in decreasing inspiratory effort and may worsen patient-ventilator
synchrony (P-Vsyn). NAVA is a new form of assistance where the ventilator is driven by
diaphragm electrical activity (EAdi). Respect to PS, NAVA has been shown to improve P-
Vsyn in intubated patients and healthy volunteers undergoing NIV.
OBJECTIVES. Physiologic comparison between PS and NAVA in delivering NIV by
helmet.
METHODS. We studied 10 patients with hypoxemic ARF. NIV was set in PS according to
patient’s requirements. During NAVA, PEEP remained unchanged and the NAVA gain was
set to achieve the same inspiratory pressure applied in PS. Three 30-min trials (PS1, NAVA,
PS2) were performed. Airway pressure (Paw) and EAdi were recorded for the last 5 min of
each trial. Respiratory rate (RR), inspiratory (TI) and expiratory (TE) time, inspiratory
(DelayTRi) and expiratory (DelayTRe) trigger delays were determined from Paw and EAdi
signals. The time in which the ventilator supported the contracting diaphragm (Tsync) was
also calculated. At the end of each trial arterial blood gases (ABGs) were measured. Data are
reported as mean ± SD.
RESULTS. ABGs did not significantly change throughout the 3 trials. Ventilator TI and TE
were 0.67 ± 0.12 s in PS1, 1.09 ± 0.34 s in NAVA and 0.65 ± 0.10 s in PS2 (P \ 0.0001),
and 2.22 ± 0.99 s in PS1, 1.71 ± 0.59 s in NAVA and 2.00 ± 0.58 in PS2 (P = 0.031),
respectively. DelayTRi was 0.31 ± 0.13 s in PS1, 0.13 ± 0.05 s in NAVA and 0.36 ± 0.12 s
in PV2 (P \ 0.0001). Tsync was 0.59 ± 0.30 s in PS1, 0.79 ± 0.34 s in NAVA and
0.54 ± 0.29 s in PS2 (P = 0.0019). RR and DelayTRe were not different between trials.
CONCLUSIONS. Compared to PS, NAVA improved P-Vsyn without affecting ABGs and
RR.
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RESPIRATORY SYSTEM RESPONSE TO EXCESSIVE RESPIRATORY MUSCLE
UNLOADING DURING NEURALLY ADJUSTED VENTILATORY ASSISTANCE
(NAVA) IN PATIENTS UNDER WEANING
G. Ferreyra1, L. Appendini2, L. Barberis1, C. Burzio1, L. Del Sorbo1, F. Racca1, M. Pizzio1,
L. Mascia1, V. M. Ranieri1
1University of Turin, Anesthesiology and Critical Care, Turin, Italy, 2Fondazione Salvatore
Maugeri, Pneumology, Veruno, Italy
BACKGROUND. NAVA is an assisted ventilatory mode that generates pressure in the
airways proportionally (with variable gain) to the electrical activity of the diaphragm (EAdi).
We aimed to assess the physiological response to increasing gain levels of NAVA on dia-
phragm unloading in patients under weaning.
METHODS. Fourteen intubated, mechanically ventilated patients (71.5 ± 10 years old) on
NAVA ventilation entered the study. Tidal volume (VT), peak airway pressure (Pawpeak),
EAdi expressed as percentage of its maximum (Edi/Edimax), inspiratory (PTPes) and dia-
phragm (PTPdi) muscle effort were continuously measured throughout the procedure. NAVA
gain was progressively increased by 0.1 cmH2O/lV every minute until Pawpeak reached
40 cmH2O.
STATISTICS. Comparisons within groups: paired t test; comparisons between groups:
unpaired t test. Significance was set at P \ 0.05.
RESULTS. VT and Pawpeak initially increased significantly with increasing NAVA gain in all
patients. Subsequently, VT and Pawpeak remained stable (plateau phase) due to decreases of
EAdi inversely proportional to the progressive increases of NAVA gain. In each patient a
NAVA gain threshold (NAVAH) was reached (2.3 ± 1.3 cmH2O/lV), above which VT and
Pawpeak increased over the plateau phase values (see Table 1). In six patients, EAdi remained
stable above NAVAH (EAdiS), while in the remaining eight patients EAdi even increased
above plateau phase values (EAdiI). In this latter condition, inspiratory flow increased to
levels known to elicit a positive feedback on the respiratory drive (Younes J Appl Physiol 89:
481, 2000).
CONCLUSIONS. We conclude that in patients under weaning: (1) downregulation capa-
bilities of respiratory drive are impaired when NAVA gain is above the patient’s NAVA gain
threshold; (2) reflexes activated by high inspiratory flow above NAVAH increase EAdi,
further contributing to increase the pressure applied to the airways. On the clinical point of
view, NAVA gains forcing pressure and VT to exceed plateau phase values and causing high
inspiratory flow (above 1 L/s) must be avoided.
Fluid management: 0011–0015
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PROSPECTIVED RANDOMIZED CONTROLLED TRIAL COMPARING PERIOP-
ERATIVE FLUID MANAGEMENT METHODS ON MAJOR LUNG SURGERY:
PRELIMINARY RESULTS
A. Pasqualetto1, A. Sabate´ Pes1, I. Camprubı` Sociats1, E. Boza Hernandez1, A. Madrid
Crespo1
1Hospital Universitario de Bellvitge, Anesthesiology, Barcelona, Spain
Improvements in the perioperative management of the patients undergoing pulmonary
resections have reduced postoperative complication rates steadily in the last several decades.
However, postresection respiratory failure, particulary ARDS, remains a major cause of
morbidity and mortality, with a variable incidence of 2–5% and a mortality of 45–50%. The
aetiology of postoperative acute lung injury (PALI) is not all over clear, even if the high
concentration of protein in the edema fluid and delayed presentation suggest this is an
inflammatory mediated process, exacerbated by excessive fluid administration and changes in
pulmonary vascular permeability.
We analyzed if guiding intraoperative and postoperative fluid management by an algorithm
based on optimizing the global end-diastolic volume index (GEDVI) and normalizing the
extravascular lung water (EVLWI) reduces the need of inotropic and vasopressor support, the
incidence of postoperative complications and the ICU stay.
DESING AND SETTING. Single-centre clinical prospective randomized study including 50
patients undergoing major lung resection surgery monitored with PiCCO 2 Pulsion Systhem
(PiCCO 2 Group, P2G), compared with a control group of 50 patients monitored with IBP and
CVP (CVPG). A standardized anaesthetic protocol was used during surgery for both groups.
RESULTS. In the P2G, hemodynamics goals were: GEDVI: 650–800 ml/m2, EVLWI: 3–
7 ml/kg, CI: 2.5–3.5 l/min/m2, SVRI: 1,700–2,400 dynes s cm-5 m2; in the CVPG, hemo-
dynamics targets were: PAM[70 mmHg, CVP: 6–10 mmHg. The preliminary results suggest
fewer administration of vasopressors and inotropics in the P2G; they received similar volume
of colloids and crystalloids, without difference on the renal function outcome. The time until
achieving criteria for ICU discharged was shorter in the P2G, with fewer incidence of
postoperative pulmonary edema, ARDS and pneumonia.
CONCLUSIONS. Guiding fluid therapy by an algorithm based on a GEDVI and an EVLWI
targets, leads to a shortened and reduced use of vasopressors, catecholamines, mechanical
ventilation, and ICU stay in patients undergoing major lung resection surgery.
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INFUSION OF BALANCED 6% HES 130/0.4 REDUCES PERICAPILLARY EDEMA
FORMATION IN THE MYOCARDIUM OF ENDOTOXEMIC SHEEP
C. Ertmer1, S. Rehberg1, G. Ko¨hler2, T. G. Kampmeier1, C. Ho¨hn1, A. Morelli3, B. Bollen
Pinto1, M. Lange1, H. Van Aken1, M. Westphal1
1University of Muenster, Department of Anaesthesiology and Intensive Care, Muenster,
Germany, 2University of Muenster, Department of Pathology, Muenster, Germany, 3Uni-
versity of Rome ‘La Sapienza’, Department of Anesthesiology and Intensive Care, Rome,
Italy
In the presence of hypovolemia, colloid infusion may reduce the amount of fluid needed for
resuscitation as compared to crystalloids. In addition, balanced solutions as compared to
saline-based solutions, may reduce the sodium and chloride load and therefore prevent
metabolic acidosis. However, the impact of specific colloid preparations on organ function
and microcirculation is still unclear. The purpose of the present study was to compare the
effect of balanced crystalloids, as well as balanced and saline-based 6% HES 130/0.4 on
myocardial microcirculatory edema formation in ovine endotoxemic shock.
Thirty-five awake sheep were subjected to incremental doses of endotoxin (started at 5 ng/kg/
min and doubled every hour) until mean arterial pressure (MAP) fell below 65 mmHg.
Thereafter, fluid resuscitation was initiated to maintain central venous pressure at 8–
12 mmHg and pulmonary arterial occlusion pressure at 12–15 mmHg. In sheep allocated to
the colloid groups, either balanced (Volulyte 6%, n = 10) or saline-based HES (Voluven
6%, n = 10) was infused until the maximum dose of 50 mL/kg was reached. In the crystalloid
group (n = 10), a balanced, isotonic crystalloid (Jonosteril) was infused to achieve goal
values. The control group (n = 5) received no volume resuscitation. In all groups norepi-
nephrine was titrated to achieve a MAP C65 mmHg. After 4 h of treatment, sheep were
anesthetized, intubated and thoracotomized. Thereafter, multiple 1 mm3 samples of left
ventricular myocardium were extracted from the beating heart. Samples were immediately
prepared for transmission electron microscopic evaluation of capillary area and edema for-
mation. Data are given as median (25; 75% range).
Capillary area was higher in the resuscitated groups as compared to the control group.
Capillary area [lm2]: Control, 25 (20; 37); Crystalloid, 39 (26; 53); Balanced HES, 33 (26;
47); Saline-based HES, 45 (31; 68); P \ 0.001).
Edema formation was highest in the crystalloid and lowest in the balanced HES group. Edema
area [lm2]: Control, 39 (26; 57); Crystalloid, 101 (76; 132); Balanced HES, 15 (5; 37);
Saline-based HES, 72 (43; 120); P \ 0.001.
The ratio of capillary to edema area was highest in the balanced HES and lowest in the
crystalloid group. Ratio capillary/edema area [%]: Control, 66 (45; 120); Crystalloid, 35 (27;
48); Balanced HES, 271 (83; 750); Saline-based HES, 54; (36; 120); P \ 0.001.
The present study provides evidence that balanced 6% HES 130/0.4 may reduce myocardial
pericapillary edema formation in ovine endotoxemic shock as compared to crystalloids or
saline-based HES.
TABLE 1






Pawpeak (cmH2O) 22.1 ± 6 25.4 ± 7 22.5 ± 5 31.8 ± 6.6
VT (ml) 550 ± 110 617 ± 100 540 ± 80 740 ± 340
Flow (L/m) 0.75 ± 0.11 0.85 ± 0.07 0.88 ± 0.21 1.19 ± 0.28*
EAdi (%) 20% ± 9% 21 ± 9% 26 ± 12% 37 ± 14% *
PTPdi (cm H2O s/
min)
35.7 ± 52.5 32.3 ± 46.5 85.7 ± 41.9 115 ± 61.4 
Mean ± SD. *P \ 0.05, NAVA.H between groups; P \ 0.05, NAVA.H versus
Plateau Phase within groups
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FLUIDS AFTER CARDIAC SURGERY (FACS): RESUCITATION WITH COLLOIDS
VERSUS CRYSTALLOIDS
S. Magder1, B. Potter1, D. Fergusson2, B. de Verennes1
1McGill University, Medicine, Montreal, Canada, 2University of Ottawa, Medicine, Ottawa,
Canada
RATIONAL. Colloids solutions are frequently used for volume resuscitation but their role is
still controversial. We argue that the failure to find an advantage for colloids over crystalloid
solutions is because protocols have not used appropriate physiological end-points and are not
flow-based. Accordingly, we used a randomized double blind trial to compare the use of a
pentastarch (HES) (MW 260 Kd) versus 0.9% saline (Sal) for volume resuscitation following
cardiac surgery. The primary end-point was the use of catecholamines between 8:00 and 9:00
the morning after surgery for this is when the decision is made to discharge patients from the
ICU.
METHODS. All patients undergoing elective cardiac surgery were eligible. Consent was
obtained prior to surgery but randomization occurred postoperatively. Exclusion criteria
included excessive bleeding, presence of intra-aortic balloon pump, absence of pulmonary
artery catheter and unstable hemodynamics. Triggers for fluid were cardiac index (CI)\2.2 l/
min/m2, mean blood pressure or systolic pressure less than the target set by treating physi-
cians, central venous pressure (CVP) \3 mmHg, or urine output \20/ml/h. In this nurse
driven protocol blinded boluses were 250 ml and the patients were assessed as being volume
responsive by assessing the CI and CVP after every bolus. When not volume responsive
catecholamines were started and tapered up or down based on an algorithm. The maximum
dose of study fluid was 1 l. An additional 500–750 of HES was used to prime the bypass
circuit in the OR for all patients.
RESULTS. There were 119 HES and 118 Sal who received fluid. An additional 26 did not
require fluid. Between 8:00 and 9:00, 13 (10.9%) HES and 34 (28.8%) Sal were on cate-
cholamines for a relative risk reduction (RR) of 0.38 and confidence interval (CI) of 0.21,
28.8, P = 0.001. There was also less total catecholamine use and less time on catecholamines
and a lower fluid balance (-656, CI -1203, -108, P = 0.02). Important secondary end-
points were a reduction of pneumonia/mediastinal infections in the HES (RR = 0.2, CI 0.04,
0.89, P = 0.03), reduction of cardiac pacing (RR = 0.23, CI 0.07, 0.78) and a tendency for
less returns to the unit (RR 0.5, CI 0.22, 1.11, P = 0.09). On the safety side, there was one
death in each group (1.7%). There was no difference in renal function in the two groups; 16%
in each reached RIFLE risk or greater and only one in each group required dialysis. There was
no significant increase in use of red blood cells but there was a significant increase in the use
of plasma in HES.
SUMMARY. In this flow-based protocol, HES use significantly reduced catecholamine use
the morning after surgery and showed trends to better outcome parameters with no negative
effects on renal function. (ClinicalTrial.gov identifier NCT00337805).
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EFFECTS OF ALBUMIN ADMINISTRATION ON ACID-BASE BALANCE
IN HYPOALBUMINEMIC PATIENTS
K.-M. Lee1, D.-K. Kim1, W.-K. Kwon1, N. S. Woo1
1Konkuk University Hospital, Anesthesiology and Crit Care Med, Seoul, Korea, Republic of
INTRODUCTION. Compensatory acid-base changes occur as a part of normal acid-base
homeostasis in response to the abnormalities of strong ion difference or PaCO2. There is a
respiratory compensation in response to primary disturbances in the strong ion difference and
controlled renal compensation in response to primary disturbances of the PaCO2. Hypopro-
teinemia and hperproteinemia by themselves may cause metabolic alkalosis and acidosis,
respectively. However, the compensatory response to the change of blood protein concen-
tration is not clear.
OBJECTIVES. This study was performed to evaluate the effects of albumin administration
on acid-base balance in hypoproteinemic patients.
METHODS. We studied 31 adult hypoalbuminemic (albumin concentration less than 3.0 g/
dL) patients who admitted to surgical ICU after receiving cardiovascular surgery. Twenty-one
patients were enrolled to the Non-AKI (non-acute kidney injury) group and ten patients were
enrolled to the AKI group. Following inclusion criteria of AKI were used: an abrupt (within
48 h) reduction in kidney function currently defined as an absolute increase in serum creat-
inine of either C0.3 mg/dL or a percentage increase of C50% (1.5 fold from baseline) or a
reduction in urine output (documented oliguria of \0.5 mL/kg/h for [6 h. Patients were
excluded if younger than 18 years, in shock state (mean arterial pressure less than 60 mmHg),
receiving transfusion, or hemodiafiltration. We administered intravenously 100 ml of 20%
albumin solution for 10 h. Patients were blood sampled from radial artery at baseline, 1 day
after the albumin administration (Day 1), and 2 days after the administration (Day 2). We
measured serum albumin concentration, chemistry values, and blood gas values. All data are
expressed as mean ± SD. Mann–Whitney test and Friedman test were used for statistical
analysis.
RESULTS. Albumin concentrations increased in both groups with the administration of
albumin (Table 1). The pH was not changed significantly in both groups. Albumin admin-
istration decreased Cl- and increased SID in Non-AKI group and these findings were not
observed in AKI group. PaCO2 was lower in AKI than Non-AKI on Day 1.
CONCLUSIONS. These data suggest that the change of albumin concentration accompa-
nies metabolic compensation with Cl- regulation. Albumin administration may develop
acidosis in renal dysfunction patients if they are depressed in ventilatory function.
REFERENCE(S). 1. Wilkes P (1998) J Appl Physiol 84:1740
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TRANSFUSION OF STORED LEUCODEPLETED RED BLOOD CELLS CAUSES
CARDIAC, PULMONARY AND RENAL DYSFUNCTION AND INJURY
N. N. Patel1, H. Lin1, C. Jones1, P. Ray2, T. Toth3, P. Sleeman1, R. Cardigan4,
G. D. Angelini1, G. J. Murphy1
1University of Bristol, Bristol Heart Institute, Bristol, United Kingdom, 2North Bristol NHS
Trust, Department of Anaesthesia, Bristol, United Kingdom, 3North Bristol NHS Trust,
Department of Histopathology, Bristol, United Kingdom, 4NHS Blood and Transplant Centre,
Cambridge, United Kingdom
INTRODUCTION. Clinical studies have demonstrated associations between allogenic red
blood cell (RBC) transfusion and organ dysfunction, particularly acute kidney injury (AKI)
and transfusion associated lung injury (TRALI), however, causality has not been established
and doubts remain as to the potential toxicity of RBC transfusion. The aim of this study was to
determine whether transfusion has a causal effect on the development of AKI and TRALI in a
large animal experimental model and to determine the changes that occur in stored porcine
SAG-M RBC units and how closely they parallel those of stored human RBCs.
METHOD. Adult White-Landrace pigs (50–70 kg, n = 20) were randomised in a 1:1 ratio to
either RBC transfusion or sham procedure. Perfusion pressure, central venous filling pressure
and hydration were standardised. Endpoints included serial functional and biochemical
measures of cardiac, pulmonary and renal injury. All pigs were recovered for 24 h prior to
organ harvest and histological assessment of injury, inflammation and endothelial activation.
RESULTS. Transfused pigs received 1,000 ml (4 units) of cross-matched allogenic leucode-
pleted RBC stored in SAG-M preservative for 42 days. Accumulation of toxic metabolites
within the supernatant as well as cellular changes showed considerable homology to those
measured in SAG-M stored human RBC units. RBC Transfusion elicited AKI manifest by a 14%
reduction in creatinine clearance (mean difference 36.1 (95% CI 3.5–68.8) ml/min, P = 0.03),
a 46% reduction in free water clearance (mean difference 32.3 (95% CI 4.0–60.7) ml/min,
P = 0.04) and a 69% increase in the urinary protein/creatinine ratio (mean difference 14.6 (95%
CI 1.8–27.4) mg/mmol, P = 0.03) when compared to controls at 24 h. RBC transfusion
resulted in a 69% reduction in the intra-renal ATP/ADP ratio (mean difference 4.16 (95% CI
1.03–7.30) nmoles/mg, P = 0.02) and a 48% reduction in nitric oxide bioavailability (mean
difference 27.4 (95% CI 0.14–54.64) mmoles, P = 0.05). RBC transfusion also caused lung
injury manifest by a 10% reduction in lung compliance (mean difference 2.5 (95% CI 0.3–
4.7) ml/cmH2O, P = 0.03) and a 20% increase in inspiratory airway resistance (mean differ-
ence 1.7 (95% CI -0.1 to 3.4) cmH2O/L/s, P = 0.06), and cardiac injury manifest by a 9-fold
increase in serum troponin (mean difference 0.19 (95% CI 0.01–0.36), P = 0.04) when com-
pared to controls at 24 h. Transfusion resulted in significant changes in renal tubular
morphology with marked renal tubular dilatation and vacuolation. RBC transfusion was asso-
ciated with endothelial injury as evidenced by reduced excretion of urinary nitric oxide.
CONCLUSION. Transfusion of stored leucodepleted RBCs causes AKI, lung injury and
myocardial injury. Endothelial dysfunction may be a pathophysiological mechanism. Modi-
fication of stored RBC prior to transfusion may reduce the incidence of organ dysfunction.
Severe infections 1: 0016–0020
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IN VITRO EVALUATION OF THE MALLINCKRODT SEALGUARD ENDOTRA-
CHEAL TUBE
A. Myers1, P. Morgan1, A. Toner1, M. Scott1
1Royal Surrey County Hospital, Guildford, United Kingdom
INTRODUCTION. Ventilator associated pneumonia (VAP) has an attributable mortality of 15–
40% [1]. The endotracheal (ET) tube cuff forms a seal to enhance positive pressure ventilation and
prevent aspiration. Folds form following inflation that allow continuous microaspiration [2]. New
cuff design and material has been used in Mallinckrodt SealGuard Evac ET tubes. There is minimal
work investigating the impact of tube agitation or secretion viscosity on cuff performance.
OBJECTIVES. To compare how secretion viscosity and agitation affect performance of
Mallinckrodt Hi-Lo Evac ET tubes with polyvinyl chloride cuff and Lanz pressure regu-
lating valve (HiLo), and Mallinckrodt SealGuard Evac (SG) ET tubes (polyurethane cuff).
Viscous fluid was used to represent saliva, the main component of secretions resting above the
ET tube cuff in intubated patients.
METHODS. A universal specimen container (internal diameter 21 mm) was used to repre-
sent a trachea. A clean, dry ‘‘trachea’’ was intubated with sizes 7.0, 8.0, and 9.0 Hi-Lo and SG
tubes. Cuffs were inflated to 30 cmH2O, the minimum pressure required to create a seal. 2 ml
of Methylene Blue diluted in saline or as a viscous solution (50% KY jelly), was introduced
above the cuff. Time was measured from the introduction of fluid to the first drop passing
below the cuff (T1), and all fluid leaking past the cuff (Tc). This was repeated three times in
each size then repeated again with agitation (30 s movement in a single plane at 2 Hz every
5 min). A limit of 1 h was set to reflect intervals in subglottic secretion drainage. If leakage
was incomplete in 1 h the volume of fluid leaking past the cuff was recorded.
RESULTS. (Table 1)
CONCLUSIONS. Viscosity affects performance of ET tubes and both types perform better
with viscous fluid. SG performed better than HiLo but agitation reduces seal integrity. At size
7.0, the SG ET tube provided a good seal until agitation was applied. Due to the small area of
cuff in contact with the ‘‘trachea’’, agitation resulted in rapid and complete leak. If this is
reflected in clinical practice, the Sealguard tube may help reduce VAP but its effectiveness is
reduced with ET movement and inappropriate tube size selection.
REFERENCE(S). 1. Safdar N, Crnich C, Maki D (2005) The pathogenesis of ventilator-
associated pneumonia: its relevance to developing effective strategies for prevention. Resp
Care 60(6):725–741. 2. Lucangelo U et al (2008) Effect of positive expiratory pressure and
type of tracheal cuff on the incidence of aspiration in mechanically ventilated patients in an
intensive care unit. Crit Care Med 36(2):409–413
TABLE 1 CHANGES OF MEASUREMENTS
Baseline Day 1 Day 2
Albumin concentration
(g/DL)
Non-AKI 2.61 ± 0.29 3.04 ± 0.30 2.97 ± 0.38
AKI 2.60 ± 0.70 3.00 ± 0.30 3.18 ± 0.26
PaCO2 (mmHg) Non-AKI 30.7 ± 6.1 31.4 ± 4.2 32.5 ± 4.7
AKI 30.8 ± 5.6 29.2 ± 7.4 31.4 ± 8.9
SID (mEq/L) Non-AKI 35.5 ± 3.5 37.8 ± 3.0 38.1 ± 3.4
AKI 38.2 ± 4.1 37.9 ± 3.6 41.7 ± 5.1
Cl- (mEq/L) Non-AKI 108.5 ± 4.4 106.0 ± 3.8 104.5 ± 5.1
AKI 112.1 ± 7.5 112.0 ± 5.9 109.7 ± 3.8
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ENTEROCOCCUS FAECIUM INFECTIONS IN A SURGICAL INTENSIVE CARE
UNIT IN A GREEK HOSPITAL
A. Larentzakis1, H. Markogiannakis1, P. Drimousis1, A. Xanthaki2, M. Toutouza2,
E. Samara1, N. Pachylaki1, E.-M. Theodoraki1, D. Theodorou1, K. G. Toutouzas1,
S. Katsaragakis1
1Hippokrateion Hospital, Athens Medical School, University of Athens, Surgical Intensive
Care Unit, 1st Department of Propaedeutic Surgery, Athens, Greece, 2Hippokrateion Hospital,
Department of Microbiology, Athens, Greece
OBJECTIVE. To identify and evaluate the clinical features of patients with Enterococcus
faecium infections in our Surgical Intensive Care Unit (SICU).
METHODS. Data for all patients hospitalized in our SICU are prospectively collected in a
database. Data for cases developing ICU-acquired infections by E. faecium between 2001 and
2007 were retrieved and analyzed.
RESULTS. During the 7-year study period, 1,255 patients were hospitalized in the SICU, 287
(22.8%) of whom suffered from an ICU-acquired infection. Among the latter, 28 sustained an E.
faecium infection (9.8% of the patients with an infection and 2.3% of the total population) and
composed our study group. Mean age of the patients with an E. faecium infection was
69.4 ± 5.8 years and APACHE II score 21.9 ± 5.4 (women: n = 19, 67.8%). The underlying
surgical pathology (hospital admission diagnosis) was gastrointestinal cancer (n = 14, 50%),
acute peritonitis (n = 4, 14.4%), bowel obstruction (n = 2, 7.1%), acute pancreatitis (n = 2,
7.1%), gastrointestinal tract hemorrhage (n = 2, 7.1%), acute cholangitis (n = 2, 7.1%), pene-
trating abdominal trauma (n = 1, 3.6%) and superior artery embolism (n = 1, 3.6%). All cases
underwent operative treatment, with 11 (39.3%) of them having one or more reoperations.
Twelve patients (42.8%) underwent intestinal surgery, 6 (21.4%) esophageal/gastric surgery, 4
(14.4%) biliary tract operative procedures/cholecystectomy, 3 (10.7%) had pancreatic surgical
procedures and 3 cases (10.7%) liver surgery. Bloodstream infections (n = 18, 64.3%) and
surgical site infections (n = 8, 28.6%) constituted the most common infection sites. The isolated
microorganisms exerted high resistance to the majority of antimicrobial agents apart from lin-
ezolid (sensitivity: 100%); susceptibility to teicoplanin (64%) and vancomycin (61%) was also
particularly low. Mean SICU and hospital stay was 33 ± 5.2 and 40.8 ± 6.4 days, respectively.
Complication rate of these patients following E. faecium infection was 92.8% (n = 26) while 24
(85.7%) presented at least one organ/system failure. Septic shock was the most frequent com-
plication (n = 21, 75%) followed by respiratory failure (n = 19, 67.8%), renal failure (n = 18,
64.3%), cardiac failure (n = 17, 60.7%), thrombocytopenia (n = 11, 39.3%), coagulopathy
(n = 11, 39.3%), hepatic failure (n = 7, 25%), arrhythmias (n = 7, 25%), hypernatremia
(n = 6, 21.4%), hypercalcemia (n = 4, 14.4%), peritonitis (n = 2, 7.1%) and hemorrhage
(n = 2, 7.1%). Mortality of patients who developed an ICU-acquired E. faecium infection was
71.4% (n = 20), which was significantly higher than mortality of all other SICU patients sus-
taining ICU-acquired infections caused by other microorganisms (45.3%, P = 0.001).
CONCLUSIONS. Enterococcus faecium infections are a significant problem in SICUs due to
high associated multiresistance, morbidity and mortality. Prevention along with timely and
appropriate treatment of these infections is crucial for ICU patients’ prognosis.
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LOW USEFULNESS OF PCT IN DIAGNOSIS OF BACTERIAL INFECTION IN
PATIENTS WITH LIVER CIRRHOSIS
T. Mikula1, W. Stan´czak1, J. Cianciara1, A. Wiercin´ska-Drapało1
1Warsaw Medical University, Hepatology and AIDS, Warsaw, Poland
BACKGROUND AND AIMS. Procalcitonin (PCT) is a 116 amino acid prohormone of the
calcitonin. In severe bacterial infections PCT is synthesized by various cells of liver, lungs,
brain and colon. PCT, beside CRP (C-Reactive Protein) is widely used marker of inflam-
mation. In healthy individuals, PCT plasma concentrations in immunoluminometric method
(ILMA) are lower than 0.5 ng/ml. CRP normal range is below 10.0 mg/l. The aim of the study
was evaluate the value of PCT in comparison with CRP among immunocompromised patients
with liver cirrhosis in diagnosis of bacterial infections in patients.
PATIENTS AND METHODS. Clinical symptoms, bacterial or suspected of infections shorter
than 3 days were the main including criteria. Blood, urine, cirrhotic fluid cultures, swabs from
potentially infected parts of body were taken. The samples for measurement of PCT and CRP
were taken once, in the beginning of observation. We evaluated PCT serum concentration in 2
groups cirrhotic patients and group of controls. Group 1 (n = 48)—patients with compensated
liver cirrhosis, Group 2 (n = 52)—decompensated liver cirrhosis and healthy Controls
(n = 37). Serum samples of all patients were analyzed with immunoluminometric method
(ILMA). The presence of SIRS (Systemic Inflammatory Response Syndrome) were confirmed
according the last recommendations. All patients (Table 1) were divided according an
advancement of SIRS into 4 groups (No SIRS and no bacterial infections, No SIRS but with
presence of bacterial infection, SIRS and Sepsis—severe sepsis and septic shock. Strength of
correlation (r) of PCT and CRP serum concentrations were analysed. We confirmed correlation
r [ 0.5 only among patients without SIRS and bacterial infection.
CONCLUSIONS. We suggest low usefulness of PCT immunoluminometric method (ILMA)
in diagnosis of bacterial infections in patients with liver cirrhosis. Even in advanced SIRS
stages PCT concentrations can be normal. It can be result of use PCT serum concentrations
ranges for healthy individuals.
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COMPARISON OF PATIENTS WITH PNEUMOCOCCAL AND NON PEUMOCOC-
CAL PNEUMONIA ON THE INTENSIVE CARE UNIT
H. M. Peet1, S. Blakeley1, R. Bowers1
1Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom
INTRODUCTION. Five to ten percent of patients with severe community acquired pneu-
monia (CAP) require admission to the Intensive Care Unit (ICU) [1, 2]. Streptococcus
pneumoniae is the leading cause of CAP, with predominance in bacteraemic and fatal cases
with mortality up to 35%. We sought to review in detail this group of ICU admissions.
METHOD. We retrospectively identified all adult patients admitted to a general ICU with an
admitting diagnosis of pneumonia or lower respiratory tract infection, who had a positive isolate
of Streptococcus pneumoniae or positive urinary antigen over an 18 month period from Feb-
ruary 2006. Patients with a diagnosis of pneumonia or lower respiratory tract infection were
identified for comparison. Data was collected regarding case mix, outcome and activity for both
pneumococcal pneumonia (PP) and non pneumococcal pneumonia (non-PP) admissions.
Review of the case notes of those with PP was performed to identify co-morbidities.
RESULTS. There were no significant differences in case mix or severity between the 2
groups (Table 1). 37% (n = 10) of patients with PP had chronic obstructive pulmonary
disease, 37% (n = 10) alcohol excess and 29.6% (n = 8) ischaemic heart disease. Given the
small numbers, no comment can be made regarding the effect of these co-morbidities on
outcome.
CONCLUSION. Patients with proven pneumococcal pneumonia accounted for 1.5% of
admissions to ICU. The historical excess mortality associated with PP compared to other
forms of pneumonia was not seen (ICU mortality 22.2 vs. 25.7%). This may be a reflection of
a changing disease process and improving ICU management with emphasis on early intro-
duction of antibiotics and attention to management of severe sepsis.
Patients with pneumococcal pneumonia compared to non-PP are admitted to the ICU sooner
after hospital admission and have a longer ICU stay, suggesting they are sicker on presen-
tation to hospital. Despite this no increase in ICU or hospital mortality was seen suggesting
that early ICU admission for these patients is beneficial.
REFERENCE(S). 1. BTS guidelines for the management of community acquired pneumonia
in adults. Thorax 2001; 56(Suppl 4): iv 1–64. 2. Community-acquired pneumonia on the
Intensive Care Unit: secondary analysis of 17,869 cases in the ICNARC case mix programme
database. Crit Care 2006; 10:S1
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DELAY IN EXECUTION AND REMOVAL OF CENTRAL VENOUS CATHETER
INCREASES THE POTENTIAL FOR CATHETER RELATED BLOOD STREAM
INFECTION
M. P. Vizcaychipi1, V. Heaviside2, A. Knight3, S. Singh4
1Charing Cross Hospital, Imperial College Academic Healthcare NHS Trust, Anaesthesia and
Intensive Care, London, United Kingdom, 2Bart’s and the London NHS Trust, Anaesthesia
and Intensive Care, London, United Kingdom, 3Hillingdon Hospital NHS Trust, Anaesthesia
and Intensive Care, London, United Kingdom, 4Chelsea and Westminster NHS Foundation
Trust, Anaesthesia and Intensive Care, London, United Kingdom
INTRODUCTION. There is approximately 6,000 central venous catheter related blood
steam infections (CR-BSI) annually reported in the United Kingdom. The majority of CR-
BSIs occur in intensive care (1). In 2008 the UK Department of Health introduced a central
venous catheter bundle to standardise aseptic central catheter insertion. Our aim was to
identify how key clinical decision making can influence the incidence of CR-BSIs.
MATERIAL AND METHODS. This was a prospective observational study registered and
approved by the clinical effectiveness committees at Chelsea and Westminster NHS Foun-
dation Trust and Hillingdon Hospital NHS Trust. Data was accrued from critically ill patients
admitted to both trusts intensive care units from June 2005 to July 2006.
RESULTS. Forty-one patients were included in this prospective observational study. 24
patients were medical with an average intensive care stay of 16.63 days (3–53 days). Sys-
temic inflammatory response (SIRS) with a CVC in situ was indication for CVC replacement
in 15 cases (See Fig. 1). The clinical decision to replace a CVC was made in the morning
round in 24 of the cases (Table 1). The insertion of the new CVCs and removal of the old
CVCs were performed in the afternoon in 23 and 24 cases, respectively. The average time
taken from CVC insertion to radiological imaging was 31 min (02:00 h to 10 min). The
average time taken from radiological imaging to review by doctor was 81 min (03:20 h to
11 min). There was an average 3 h 36 min (10:45 h to 15 min) delay from clinical decision to
placement of a new CVC. An overlap period of the old and new CVCs of 3 h and 10 min
(06:30 h to 10 min) was identified. There was a total delay of 6 h and 27 min (15:25–01:16 h)
from clinical decision to removal of the old CVC.
CONCLUSION. In standard practice, when concerns regarding SIRS dictate a central venous
catheter change there can be a delay of almost 7 h following this initial clinical decision. To
us, the intensivist we seek to find if this is acceptable. Moreover, a delay of almost 3 h from
new catheter insertion to removal of old catheter, may provide a targeted outcome measure for
improvements in practice.
Fig. 1 Indications for removal of old CVCs
TABLE 1 CORRELATION (R) OF PCT TO CRP SERUM CONCENTRATIONS
Group 1 Group 2 Controls
Number of patients (n = 137) 48 52 37
PCT mean serum concentration (ng/ml) 1.47 2.25 0.13
CRP mean serum concentration (mg/l) 35.42 51.76 2.33
No SIRS/no infection r = 0.54 r = 0.75 –
No SIRS/infection r = 0.41 r = 0.63 –
SIRS r = 0.006 r = 0.07 –
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APACHE II score:
median (range)













1.0 (0–182) 0 (0–11) 2.0 (0–64) \0.0001
ICU LOS days:
median (range)




12 (0–285.9) 17.9 (1–79) 18.5 (0.2–115.5) NS
ICU mortality:
n (%)
284 (16.0%) 6 (22.2%) 46 (25.7%) NS
Hospital mortality:
n (%)
417 (23.5%) 7 (25.9%) 59 (33.0%) NS
aN = 1467, bN = 27, cN = 140 (missing data)
LOS length of stay
TABLE 1 TIME FRAME FOR CLINICAL DECISION




Decision to remove old CVC 10:18 (08:15–12:00) 14:28 (13:00–16:40)
Insertion of new CVC line 11:09 (10:00–12:00) 15:26 (12:30–21:45)
Removal of old CVC 10:40 17:38 (12:30–23:00)
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A PHARYNGEAL COOLING SYSTEM IMMEDIATELY DECREASES BRAIN
TEMPERATURE WITHOUT CAUSING COLD INJURY IN THE PHARYNX
Y. Takeda1, K. Shiraishi1, H. Naito2, N. Morimoto2, K. Morita1
1Okayama University Medical School, Anesthesiology & Resuscitology, Okayama, Japan,
2Tsuyama Central Hospital, Emergency and Critical Care Center, Tsuyama, Japan
If hypothermia can be initiated immediately after the onset of resuscitation, neurological
outcome would be improved. Since bilateral common carotid arteries exist at 1 cm from the
pharynx, cooling the pharyngeal region decreases brain temperature by cooling arterial blood
without lowering systemic temperature. In the present study, we investigated effects of
pharyngeal cooling on brain temperature, tympanic temperature, rectal temperature and
mucous membrane in the pharynx in monkeys and in humans.
METHOD 1. Japanese monkeys (7.5 ± 2.4 kg) were divided into a control group (n = 6)
and a pharyngeal cooling group (n = 3) and were anesthetised with 1% isoflurane. Cardiac
arrest (12 min) was initiated with electrical stimulation. In the pharyngeal cooling group, a
pharyngeal cuff was inserted into the pharynx and was perfused with saline (5C) at the rate of
500 ml/min from the onset of resuscitation for 30 min. One day (n = 1) and 7 days (n = 2)
after the initiation of pharyngeal cooling, animals were perfuse-fixed for histological evalu-
ation of the mucous membrane of the pharynx.
METHOD 2. Three resuscitated patients (77 ± 10 years) were subjected to pharyngeal
cooling for 30 min. Changes in tympanic temperature, bladder temperature, systemic blood
pressure and heart rate were monitored. Macroscopic observation of the mucous membrane of
the pharynx was performed for 3 days.
RESULTS 1. During cardiac arrest, epidural and sub-cortical temperatures decreased to
33.3 ± 0.7 and 35.8 ± 0.5C, respectively, in both groups. In the control group, however,
epidural and sub-cortical temperatures increased with the initiation of resuscitation and
reached 35.1 ± 0.5 and 36.5 ± 0.2C, respectively, 30 min later. In the pharyngeal cooling
group, epidural and sub-cortical temperatures decreased and reached 31.1 ± 1.5 and
32.4 ± 1.3C, respectively, 30 min later. Rectal temperature was unchanged in both groups.
Microscopic observation (HE staining) showed that mucous membranes of the pharynx were
intact. No inflammatory cell infiltration was observed
RESULTS 2.Tympanic temperature (36.3 ± 1.2C) was decreased to 35.7 ± 1.0C 30 min
after initiation of pharyngeal cooling. Bladder temperature (36.3 ± 0.9C), mean arterial
blood pressure (90 ± 16 mmHg) and heart rate (90 ± 24/min) were unchanged at 30 min
after initiation of pharyngeal cooling (Bladder temperature, 36.3 ± 1.0C; mean arterial
blood pressure, 96 ± 18 mmHg; and heart rate, 93 ± 21/min). Edema formation or inflam-
matory findings, suggesting development of cold injury, were not observed in the pharyngeal
mucous membrane for 3 days.
CONCLUSIONS. Brain temperatures were decreased by the initiation of pharyngeal cooling
without any effect on rectal temperature, blood pressure and heart rate in monkeys and in
humans. Since the mucous membrane in the pharynx was intact after 30 min of cooling,
pharyngeal cooling could be a useful technique for protecting the brain from ischemic injury
in a clinic.
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REFRACTORY STATUS EPILEPTICUS: APPROACH AND MANAGEMENT IN A
NEUROLOGICAL INTENSIVE CARE UNIT
O. H. Hernandez1, J. F. Zapata2, A. Franco2, M. Jimenez2, M. Massaro3, A. Guerra1, J. C.
Arango1, J. D. Ciro1, C. S. Uribe1, J. I. Suarez4
1Instituto Neurologico de Antioquia, Neurological Intensive Care Unit, Medellin, Colombia,
2Instituto Neurologico de Antioquia, Clinical Neurophysiology Unit, Medellin, Colombia,
3Instituto Neurologico de Antioquia, Research and Education Department, Medellin,
Colombia, 4Baylor College of Medicine, Department of Vascular Neurology and Neurocrit-
ical Care, Houston, United States
INTRODUCTION. Refractory status epilepticus (RSE) constitutes a medical emergency
with a significant morbidity and mortality. Management of RSE requires an accurate diag-
nosis and a rapid and aggressive treatment to successfully stop it. RSE is defined as status
epilepticus refractory to first- and second-line medications requiring general anesthesia.
OBJECTIVES. To describe the management approach of RSE in a neurological intensive
care unit (NICU).To assess the outcomes of these patients according of type of RSE and the
response to treatment.
METHODS. We conducted a retrospective study over 15 months (09/2007–12/2008) of RSE
patients. The pharmacologic treatment was guided by continuous video EEG monitoring
(CVEEGM). We collected the following information: patients’ demographics, etiology of
RSE, APACHE II score, clinical characteristics of seizures, EEG findings, treatments and
short term outcomes. We defined EEG control of the RSE as burst suppression pattern or a
decrease in the ictal activity. We performed descriptive statistics and compared proportions
using Chi-square or Fischer’s exact test as appropriate.
RESULTS. We included 80 patients with RSE. Of those, 75% had non-convulsive RSE;
51.3% were male; their mean age was 45 years; and 52.5% of them had an APACHE II score
C15. The etiology of RSE was a neurological lesion in 75.1% (48.3% stroke, 15% infection,
13.5% trauma, 23.4% other), underlying epileptic disease in 20% and systemic abnormalities
in 4.9% of patients. Our treatment included general anesthesia (continuous infusions of
midazolam, propofol and/or thiopental) and concomitant anticonvulsivants (valproic acid,
levetiracetam, topiramate and phenobarbital, among others) in 78.8% of patients. RSE was
successfully controlled within 3 days in 87.5% of patients. The EEG patterns during treatment
induction were as follows: focal electrographic seizure activity (80%); periodic discharges
(95%) and pseudoperiodic discharges (40%). The mean follow up with CVEEGM was
138 ± 73.6 h. In-hospital mortality was 22.5%. At 1-month follow up, 48.4% of patients had
regained their independent activities of daily living. The clinical and EEG features did not
affect the RSE length of treatment, length of NICU stay, RSE control and discharge condition.
Patient survival and modified Rankin scale B2 correlated positively with RSE control
achievement (82.9 vs. 40%, P 0.008; 63.6 vs. 22.2%, P: 0.003, respectively).
CONCLUSIONS. RSE is a medical emergency. ICU management of RSE by a team of
neurointensivists, neurophysiologists and neurologists, guided under CVEEG monitoring,
permits a rapid and adequate control of these patients to improve short term prognosis.
REFERENCE(S). 1. Claassen J, Hirsch LJ, Emerson RG, Mayer SA (2002) Treatment of
refractory status epilpeticus with pentobarbital, propofol or midazolam: a systematic review.
Epilepsia 43(2):146–153
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EFFECT OF ANALGO-SEDATION PROTOCOL FOR DANISH NEUROINTENSIVE
PATIENTS
I. Egerod1, M. Brorsen2, S. Herling2, K.-L. Welling2
1University of Copenhagen, Health Sciences, Copenhagen O, Denmark, 2Copenhagen Uni-
versity Hospital Rigshospitalet, 2093, Copenhagen, Denmark
AIMS. The aim of the study was to assess the effect of a sedation protocol for neurointensive
patients based on the principles of analgo-sedation. The primary objectives were a shift from
sedation-based to analgesia-based sedation (analgo-sedation) and a reduction in pain level.
Intensive care patients usually require sedation and analgesia in order to maintain comfort,
relieve anxiety, facilitate care, and adapt to ventilatory support. A recent trend in sedation
management is analgo-sedation, wherein the patient is primarily treated for pain, and, if
necessary, sedated. Guidelines have been developed for general intensive care patients
resulting in shorter duration of mechanical ventilation, shorter hospital stay, and fewer
incidences of ventilator associated pneumonia. Only few sedation protocols for neurointen-
sive patients exist, due to the difficulty in assessing the pain and sedation levels and to the
need to maintain adequate cerebral perfusion pressure, mean arterial pressure, and control
intracranial pressure.
METHODS. The design was a prospective two-phased single-center before-after study at a
14-bed NICU at a 1,082-bed university hospital in Denmark. Patients were consecutively
enrolled in the study during two 7-month periods in January through July 2007 (n = 106) and
April through October 2008 (n = 109). Patients were included if they were C18 years old,
admitted to the NICU and intubated within 24 h, mechanically ventilated and requiring
continuous infusions of sedatives and analgesics. Patients were excluded if they were
potential organ donors, non-sedated, non-intubated, or transferred intubated from other units.
RESULTS. The before and after groups were similar in sex, age, weight, APACHE II, SAPS
II, SOFA, and admission diagnosis. Hospital stay, NICU stay, duration of mechanical ven-
tilation, incidence of late pneumonia, and accidental extubation were also unchanged, but the
duration of sedation was significantly reduced from 125 to 112 (P = 0.038) mean hours of
sedation. The sedation level (Ramsay 4) and the Glasgow Coma Score, GCS (8 during
sedation breaks) were unchanged, but the pain intensity score was significantly reduced from
1.54 to 1.24 (P \ 0.000). The medication pattern shifted from sedative to analgesic infusions;
there was a significant reduction in the daily dose of propofol and midazolam, and a sig-
nificant increase in the daily dose of fentanyl, remifentanil.
CONCLUSIONS. The study confirms the feasibility of targeting issues of pain management
in the neurointensive population as a sedation protocol decreases the variability of practice
and increases staff awareness. Better assessment methods are still needed to distinguish
among levels of pain, sedation, drug accumulation and decreased level of consciousness.
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FIBRINOGENOLYSIS DURING THE EARLY STAGE OF TRAUMA PREDICTS
THE OCCURRENCE OF MASSIVE BLEEDING IN PATIENTS WITH BLUNT
TRAUMA
M. Hayakawa1, T. Wada1, K. Katabami1, M. Sugano1, N. Henzan1, H. Hoshino1,
A. Sawamura1, S. Gando1
1Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Japan
INTRODUCTION. Several reports have so far indicated that the main pathophysiology
of the coagulopathy associated with the early stage of trauma is fibrinolysis, but not the
significant consumption of coagulation factors. FDP consists of both fibrin degradation
(fibrinolysis) products and fibrinogen degradation (fibrinogenolysis) products. However,
D-dimer consists of fibrin degradation products, but excluding fibrinogen degradation prod-
ucts. In other words, a high level of FDP without a D-dimer elevation indicates a state of
fibrinogenolysis.
OBJECTIVE. We hypothesized that the levels of FDP and D-dimer on the admission could
help to predict the necessity to perform an aggressive transfusion of coagulation factors by
evaluating the balance of fibrinogenolysis and fibrinolysis in blunt trauma patients. We
investigated the characteristics of coagulopathy during the early stage of trauma, and thus
identified the predictive parameters for massive bleeding.
METHODS. Eighty-three blunt trauma patients enrolled in the study and 182 patients with
sepsis were selected as a control group. The clinical backgrounds of the patients and the
measured variables were all retrospectively collected.
RESULTS. On admission, the FDP and D-dimer levels increased in the trauma patients much
more than in the patients with sepsis. The figure shows the D-dimer/FDP % and the levels of
D-dimer and FDP in each group. The FDP and D-dimer levels markedly decreased from
admission to 24 h after admission. In the trauma patients, the D-dimmer/FDP % on admission
rapidly increased to the same percentage as that observed in patients with sepsis. In an ROC
curve analysis for the risk of massive transfusion, FDP showed a large AUC among the
various coagulation tests. The best cutoff point for FDP as an indicator for the risk of massive
transfusion was 64.1 lg/ml with a sensitivity of 76.9% and a specificity of 73.1%, and these
values were the same as when the cutoff point for D-dimmer/FDP % was 52.9%.
CONCLUSION. 1. In comparison to the patients with sepsis, more intense hyper-fibrinolysis
and fibrinogenolysis were observed in the early stage of trauma in the blunt trauma patients;.
2. the fibrinogenolysis during the early stage of trauma was promptly suppressed to same level
as that observed in the patients with sepsis;. 3. the elevation of FDP and the low percentage of
D-dimer/FDP % thus indicated the presence of fibrinogenolysis and predicted the necessity to
perform massive transfusions (Fig. 1).
Fig. 2 The change of the fibrinogenolysis
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RAPID REVERSAL OF COAGULOPATHY IN WARFARIN-RELATED INTRACRA-
NIAL HEMORRHAGES WITH PROTHROMBIN COMPLEX CONCENTRATES
(PCC)
C. T. Chong1, T. W. Lew1, P. Kuperan2, J. Tan1, H. L. Tan1, T. K. Kwek1
1Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Singapore, Singa-
pore, 2Tan Tock Seng Hospital, National Healthcare Group, Laboratory Medicine, Singapore,
Singapore
INTRODUCTION. Intracranial hemorrhage is a life-threatening complication that occurs
during warfarin oral anticoagulant therapy (OAT) with mortality in excess of 50%. Early
hematoma growth is a known predictor of poor outcome [1]. Patients presenting with OAT-
related intracranial hemorrhage thus mandate rapid PT/INR normalization to decrease the risk
of early hematoma enlargement and to facilitate early neurosurgical evacuation when
indicated.
METHODS. We reviewed all consecutive patients with OAT-related intracranial hemorrhage
admitted to our acute tertiary-level NICU and treated with PCC from January to June 2008.
All patients were on warfarin OAT for clinically appropriate indications, had INR [1.5 at
presentation with CT diagnosis of intracranial hemorrhage. In consultation with the hema-
tologist, Profilnine SD (Grisols Biologicale Inc, Los Angeles, USA), a 3-Factor PCC
containing per 100 U of factor IX, 148 U of factor II, and 64 U of factor X, was administered
with FFP (as an adjunct source of Factor VII) and Vitamin K.
RESULTS. A total of seven patients received PCC for OAT-related intracranial hemorrhage
during the 6-month period. Most of the patients had admission INR within or close to
therapeutic range of 2–3, except for one patient whose INR was 7.74.
The majority of intracranial bleeds were subdural hematomas (4/7 patients or 57%), with
significant deterioration in conscious level (GCS 3–9) requiring urgent surgical evacuation.
The mean maximum diameter of the SDHs in four patients was 18.1 mm (range 11.5–
33 mm). The mean maximum diameters of intracerebral bleeds in three patients were
45.3 mm (range 15–61 mm). The dose of PCC administered ranged from 1,000 to 3,000 IU
(equivalent to a median of 28.5 IU/kg body weight (range 14.9—63.8 IU/kg)). All four
patients with SDH underwent surgical evacuation once INR was\1.5. Median time from CT
diagnosis to surgery was 275 min (range 102–420 min).
Four of seven patients had good neurological outcome (GOS 4) at 30 days. The median time
to INR normalization post-PCC administration was shorter at 85 min (range 50 min to 7 h)
for the four patients that survived, in contrast to the three patients that died (median time 10 h,
range 9–44 h). Two of the three patients who died had CT evidence of hematoma growth,
worsening midline shift and subfalcine herniation.
CONCLUSIONS. PCC should be considered for use in the urgent reversal of OAT-related
intracranial hemorrhage, potentially halting hematoma expansion and expediting urgent
neurosurgery, although randomized trials are lacking [2]. A protocolized emergent treatment
algorithm is proposed and may achieve earlier consistent normalization of INR.
REFERENCE(S). 1. Flibotte JJ, Hagan N, O’Donnell J et al (2004) Warfarin hematoma
expansion, and outcome of intracerebral hemorrhage. Neurology 63:1059–1064. 2. Leissinger
CA, Blatt PM, Hoots WK et al (2008) Role of prothrombin complex concentrates in reversing
warfarin anticoagulation: a review of the literature. Am J Hematol 83(2):137–143
Resource consumption in ICU: 0026–0030
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THE INCIDENCE OF SEVERE SEPSIS: THE INFLUENCE OF DEFINITIONS
P. J. Watkinson1, S. M. Drage2, V. S. Barber1, S. Lowes2, J. D. Young1
1University of Oxford, Intensive Care Society Trials Group, Oxford, United Kingdom,
2Brighton and Sussex University Hospitals NHS Trust, Intensive Care, Brighton, United
Kingdom
INTRODUCTION. Consensus Conference [1] and PROWESS study [2] criteria have
become the standard definitions upon which most studies of severe sepsis in intensive care
units (ICUs) are based. These definitions require evidence of infection and abnormalities in
physiological variables that define the SIRS (systemic inflammatory response syndrome) and
organ failure components of severe sepsis. These abnormalities can be present, even tran-
siently, at any point in the previous 24 h to make the diagnosis. However, clinicians tend to
make a clinical diagnosis of severe sepsis if all or most the abnormalities are present
simultaneously. It is unknown whether these differing definitions can explain the discrepancy
between the incidence of severe sepsis in observational studies and recruitment rates to trials
of agents for the treatment of severe sepsis. This study investigated the effect of the timing of
SIRS and organ failure criteria on the incidence of severe sepsis. It also assessed whether the
use of two (original Consensus Conference definition) or three (PROWESS study) SIRS
criteria altered the incidence of severe sepsis.
OBJECTIVES. To quantify the effect of different definitions on the incidence of severe
sepsis.
METHODS. An observational study was carried out within a randomised controlled trial in
three ICUs in England. 1,002 consecutive patients were screened each morning at 1,000 h.
Any infective diagnosis was recorded. Organ failure and SIRS criteria were determined from
the most current data and from data at anytime within the previous 24 h.
RESULTS. The incidence of sepsis in the first 24 h following admission varied from 26.4%
of admissions if the PROWESS study criteria were used with the most recent results, to 37.3%
if the Consensus Conference criteria were used with the most extreme values in the previous
24 h. The prevalence of severe sepsis (proportion of patient days when patients met the
criteria) varied from 18.5% (PROWESS study criteria, most recent values) to 46.9% (Con-
sensus Conference criteria, 24 h values). Two SIRS criteria were present in a 24 h period in
91% of patients, and no patient simultaneously had three SIRS criteria without infection.
CONCLUSIONS. Severe sepsis, far from being a clear clinical entity, has an incidence
heavily dependent on the diagnostic criteria. Identifying suitable patients for trials of specific
treatments using techniques so sensitive to timing and a difference of one variable may recruit
the wrong subjects. The different criteria used in epidemiological studies of severe sepsis may
partially account for the differing reported incidences.
REFERENCE(S). 1. Levy MM et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS Interna-
tional Sepsis Definitions Conference. Intensive Care Med 29:530–538. 2. Bernard GR et al
(2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N
Engl J Med 344:699–709
GRANT ACKNOWLEDGEMENT. Moulton Charitable Foundation, University of Oxford
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VANCOMYCIN ADMINISTRATION DOES NOT INCREASES HEMODIALYSIS-
HEMOFILTRATION REQUIREMENTS MORE THAN OTHER ANTIBIOTICS
USED IN SEVERE SEPSIS
J. Massaut1, O. Noordally2, F. Corrazza3, P. Reper2
1U.L.B, Intensive Care, Bruxelles, Belgium, 2CHU Brugmann, Intensive Care, Bruxelles,
Belgium, 3CHU Brugmann, Laboratory, Bruxelles, Belgium
INTRODUCTION. Potentially nephrotoxic antibiotics have been incriminated as causes of
increased need of hemodialysis in intensive care patients based on historical evolution [1].
OBJECTIVES. To evaluate the incidence of vancomycin administered as continuous
intravenous infusions on hemodialysis needs in our intensive care we reviewed the evolution
of 1,263 consecutives patients and analyzed the effect of all antibiotics treatments on he-
modialysis–hemofiltration (HH) requirements.
METHODS. We analyzed the data stored in our intensive care data management system [2]
updated with laboratory data to systematically review all the antibiotic administrations and
the creatinine blood level during these treatments and their relations to consecutive needs of
HH. Data were analyzed by univariate and multivariate logistic regression. P values \0.05
were considered as significant. Variables significantly linked to HH at the univariate analysis
were entered in the multivariate logistic regression. For statistical analysis, we used Stata 8 for
UNIX. Target for vancomycin infusion was between 20 and 35 mcg/ml.
RESULTS. Thirty-seven patients of 1,263 (2.9%) received HH. 549 (19.71%) patients received
antibiotics. Vancomycin, Meropenem, Piperacilin-Tazobactam, Fluconazole treatments and
creatinine blodd levels above 2 mg/dL during treatment were significantly associated with the
necessity of HH, but LROC values, respectively, of 0.53, 0.53, 0.56, 0.54 for these treatments
were very low compared to LROC values of 0.75 for creatinine above 2 mg/dL. Table 1 shows
odds ratios, P values and confidence interval for the multivariate analysis.
DISCUSSION. Vanmycin administration is significantly associated to the need of HH at the
univariate and multivariate analysis, but this is also true for other antibiotics not known as
nephrotoxic and used in severe sepsis. Odds ratio for vancomycin at the multivariate analysis
is not different from odds ratio for meropenem and Piperacilin-Tazobactam and may reflect an
association and not a cause effect relationship.
CONCLUSIONS. Based on our data from 1,263 intensive care consecutive patients, van-
comycin administration does not increases HH requirements more than other antibiotics used
in severe sepsis.
REFERENCE(S). 1. Eichorn ME et al (2007) Secular trends in severe renal failure asso-
ciated with the use of new antimicrobial agents in critically ill surgical patients. Eur J Clin
Microbiol Infect Dis 26:395–402. 2. Massaut J, Reper P (2008) Open source electronic health
record and patient data management system for intensive care. Stud Health Technol Inform
141:139–145
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COST ANALYSIS OF COMPUTER-ASSISTED GLUCOSE REGULATION PRO-
GRAM IN THE INTENSIVE CARE UNIT
M. Hoekstra1, K. Vermeulen2, M. Vogelzang3, I. C. C. van der Horst3, J. van Pelt4,
F. Zijlstra3, E. Buskens2, M. W. N. Nijsten5
1University Medical Center Groningen, Departments of Anesthesiology and Cardiology,
Groningen, Netherlands, 2University Medical Center Groningen, Department of Epidemiol-
ogy, Groningen, Netherlands, 3University Medical Center Groningen, Department of
Cardiology, Groningen, Netherlands, 4University Medical Center Groningen, Department of
Laboratory Medicine, Groningen, Netherlands, 5University Medical Center Groningen,
Department of Intensive Care, Groningen, Netherlands
INTRODUCTION. As recommended by recent guidelines, glucose control (GC) has been
implemented in many ICU’s. Several studies have hinted that GC is associated with con-
siderable costs. In our ICU glucose is regulated by a nurse-driven computerized clinical
decision support system that was designed to improve patient safety and optimize glycaemic
control [1].
OBJECTIVE. To determine the costs of GC as performed by a computerized protocol using
point-of-care blood glucose measurements.
METHODS. We comprehensively analyzed all the costs of (computer-assisted) glucose
regulation in a mixed ICU (45 beds) in a regional university teaching hospital that covers all
adult patient specialties. The effectiveness of GC was determined in terms of achieved glu-
cose levels and incidence of severe hypoglycaemia (glucose \2.2 mmol/L).
RESULTS. The variable costs of glucose management (including personnel costs) were €7.88
per point-of-care measurement, the fixed costs were €4.68 per patient per day. For our ICU the
total costs of glucose regulation with 5.6 point-of-care glucose measurements per patient per
day were €48.80. In an alternative scenario where the regulation program would use more
frequent glucose measurements, as the majority of published glucose regulation protocols do
(i.e. 12–18 measurements/day), this sum increases to €100–€150 per patient per day. In 5,898
consecutive ICU patients glucose regulation was effective with the blood glucose within the
predefined target range (4.0–7.5 mmol/L) in two-thirds of the time. Severe hypoglycaemia was
uncommon (0.05% of measurements \2.2 mmol/L, 1.0% of patients experienced an episode
\2.2 mmol/L). No mortality or morbidity could be related to hypoglycaemia.
CONCLUSION. Glucose control, as achieved with the assistance of an effective and efficient
computer-assisted program, costs an estimated €50 per day per ICU patient. Altogether,
including 35% overhead costs, for our institution (45 beds) this leads to approximately
€1.100.000 per year. The major cost-determining factor was the number of point-of-care
glucose measurements per day. Compared to other published computerized glucose protocols,
using more frequent measurements, our institution achieved major absolute and relative cost
savings (approximately 50%) by applying 5.6 measurements per day. However, even with a
system designed to optimize GC, costs are considerable.
REFERENCE(S). 1. Vogelzang M, Loef BG, Regtien JG (2008) Computer-assisted glucose
control in critically ill patients. Intensive Care Med 34:1421–1427
TABLE 1 MULTIVARIATE ANALYSIS
Odds Ratio P value 95% CI high 95% CI low
Vancomycin 5.21 0.001 1.92 14.12
Meropenem 5.78 0.002 1.93 17.30
Pipe-Tazo 3.47 0.001 1.60 7.37
Fluconazol 5.67 0.001 1.94 16.55
Creatinine [2 mg/dL 16.74 0.001 2.99 93.57
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ROUTINE AND ON-DEMAND PRESCRIPTION OF CHEST RADIOGRAPHS IN
MECHANICALLY VENTILATED ADULTS: A MULTICENTER CLUSTER-RAN-
DOMIZED TWO-PERIOD CROSS-OVER STUDY
B. Guidet1, G. Hejblum2, L. Chalumeau-Lemoine3, V. Ioos3, C. E. Luyt3, J. L. Diehl4,
L. Salomon5, T. Simon6, E. Schouman-Claeys7, RARE
1UFR Saint Antoine, Re´animation Me´dicale, Paris, France, 2U707, INSERM, Paris, France,
3Paris VI, Re´animation Me´dicale, Paris, France, 4Paris V, Re´animation Me´dicale, Paris,
France, 5Paris VII, Sante´ Publique, Colombes, France, 6Paris VI, URC Est, Paris, France,
7Paris VII, Radiology, Paris, France
BACKGROUND. Current guidelines recommend Routine daily chest radiographs (CXRs)
for mechanically ventilated patients in intensive care units (ICUs). However, some ICUs have
shifted to an On-demand strategy, in which this CXR is only prescribed if warranted by the
patient’s status at the morning physical examination. Here we compared Routine and On-
demand strategies in 21 French ICUs. The working hypothesis was that CXR prescriptions
would fall by at least 20% with the On-demand strategy, with no reduction in quality of care.
METHODS. Based on a cluster-randomized two-period two-strategies cross-over design,
respectively, 11 and 10 participating ICUs applied the Routine and On-demand strategies
during the first period, each enrolling 20 consecutive patients requiring mechanical ventilation
for at least 2 days. Each ICUs applied then applied the alternative strategy during the second
period, again enrolling 20 consecutive patients.
FINDINGS. Respectively 424 and 425 patients received 4,607 and 3,148 CXRs with the
Routine and On-demand strategies, representing a reduction of 32% with the On-demand
strategy (P \ 10-6). Similar numbers of CXRs (respectively 728 and 729) led to therapeutic
or diagnostic interventions. The two strategies were associated with similar mean durations of
mechanical ventilation (9.82 and 9.84 days) and ICU stay (13.96 and 13.21 days), and similar
ICU mortality rates (30.9 and 32.0%).
INTERPRETATION. An On-demand prescription strategy reduces CXR consumption with
no measurable change in quality of care.
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COST-EFFECTIVENESS OF THE SURVIVING SEPSIS CAMPAIGN IN SPAIN
R. Ferrer1, Edusepsis Study Group
1Sabadell Hospital. CSPT. UAB. CIBER-ER., Sabadell, Spain
INTRODUCTION. In Spain, a multicenter (59 ICUs) prospective before and after educa-
tional study (Edusepsis, Ferrer et al. JAMA 2008) based on the Surviving Sepsis Campaign
(SSC) was able to improve care and reduce mortality.
OBJECTIVE. To compare in terms of cost-effectiveness the protocol of the SSC in Spain for
the treatment of severe sepsis after the implementation of a multicentre educational program
with the conventional care of severe sepsis.
METHODS. Post hoc cost-effectiveness analysis. Costs and effectiveness were calculated in
the preintervention and the postintervention cohorts. Calculation of costs was done from the
health care system perspective, costs were not discounted and timeline horizon was from
sepsis onset to hospital discharge. Calculation of effectiveness: Life-Years Gained (LYG) and
Quality Adjusted Life Years (QALYs). The age and gender specific life expectancy for each
hospital survivor was estimated using ‘‘2005 Mortality tables. National Institute of Statistics,
Spain’’. The previous life expectancy was adjusted by 0.51, the estimated life reduction for
sepsis survivors (Quartin et al. 1997) to obtain the LYG. LYG were adjusted by a utility
weight of 0.69 to get the QALYs (Davies et al. 2005). The end-points of the study were:
Incremental Cost-Effectiveness Ratio (ICER) and Incremental Cost-Utility Ratio (ICUR).
RESULTS. Cost and effectiveness data from the preintervention and the postintervention
cohort are shown in Table 1.
Main costs were related to hospital stay. The ICER per LYG was 2556.9€ and the ICUR per
QALY was 3579.6€.
CONCLUSIONS. The ICER of the SSC in Spain was less than 30.000€/LYG. Therefore, it is
a cost-effectiveness intervention.
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TABLE 1 COST AND EFFECTIVENESS RESULTS
Preintervention cohort Intervention cohort
(n = 854) (n = 1465)
Length of Stay, days
ICU 12.6 (16.4) 13.7 (18.1)
Ward 11.0 (16.9) 12.7 (18.3)
Overall 23.6 (25.6) 26.4 (27.7)
Costs, 2006 Euros 16937.1 (19042.6) 18726.9 (21082.6)
Mortality, n (%) 376 (44.0) 580 (39.6)
LYG 6.7 (8.2) 7.4 (8.3)
QALYs 4.6 (5.6) 5.1 (5.7)
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